U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C6H6N4O3S
Molecular Weight 214.202
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NIRIDAZOLE

SMILES

[O-][N+](=O)C1=CN=C(S1)N2CCNC2=O

InChI

InChIKey=RDXLYGJSWZYTFJ-UHFFFAOYSA-N
InChI=1S/C6H6N4O3S/c11-5-7-1-2-9(5)6-8-3-4(14-6)10(12)13/h3H,1-2H2,(H,7,11)

HIDE SMILES / InChI

Molecular Formula C6H6N4O3S
Molecular Weight 214.202
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Niridazole is used (but not officially recommended) for the treatment of schistosomiasis, dracunculiasis and tungiasis. The mode of action of niridazole is not fully understood. The major action of niridazole seems to be on the glycogen metabolism of the helminths. The drug also case structural damage to the reproductive system of female schistosomes. Another possible mechanism of action of niridazole involves the inhibition of DNA synthesis in schistosomes. It is metabolized in the liver. The most serious side effects were those connected with the nervous area (convulsion, hallucination, etc.).

Approval Year

PubMed

PubMed

TitleDatePubMed
Treatment of amebic liver abscess with emetine hydrochloride, niridazole, and metronidazole. A controlled clinical trial.
1974 Jul
Anthelmintics: a review.
2001 Oct-Dec
Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841].
2005 Sep 22
Patents

Sample Use Guides

25 mg/kg given for 5-7 days or 30 mg/kg for 4 days
Route of Administration: Oral
In Vitro Use Guide
Niridazole was dissolved in dimethyl sulfoxide to obtain a solution at 1,000 ug/ml. It was further diluted in distilled water and mixed with Mueller-Hinton agar to obtain graded concentrations from 0.001 to 8 ug/ml. The minimal inhibitory concentrations of niridazole for C. fetus subsp. Jejeuni was substantially higher than that of metronidazole. The break point of niridazole may tentatively be fixed between 4 and 8 ug/ml of active drug.
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:03:42 GMT 2023
Edited
by admin
on Fri Dec 15 15:03:42 GMT 2023
Record UNII
N116U8Y5QQ
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NIRIDAZOLE
HSDB   INN   MART.   MI   USAN   WHO-DD   WHO-IP  
INN   USAN  
Official Name English
BA 32644
Code English
NSC-136947
Code English
CIBA 32644BA
Code English
BA-32644
Code English
NIRIDAZOLE [USAN]
Common Name English
NIRIDAZOLE [MART.]
Common Name English
NIRIDAZOLE [IARC]
Common Name English
Niridazole [WHO-DD]
Common Name English
niridazole [INN]
Common Name English
NIRIDAZOLUM [WHO-IP LATIN]
Common Name English
NIRIDAZOLE [HSDB]
Common Name English
NIRIDAZOLE [WHO-IP]
Common Name English
NIRIDAZOLE [MI]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C277
Created by admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
WHO-ATC P02BX02
Created by admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
IARC Niridazole
Code System Code Type Description
INN
2234
Created by admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
PRIMARY
NCI_THESAURUS
C90757
Created by admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
PRIMARY
WHO INTERNATIONAL PHARMACOPEIA
NIRIDAZOLE
Created by admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
PRIMARY Description: A yellow, crystalline powder; odourless or almost odourless. Solubility: Practically insoluble in water and ether R; soluble in dimethylformamide R and pyridine R; slightly soluble in ethanol(~750 g/l) TS and acetone R. Category: Antischistosomal drug.Storage: Niridazole should be kept in a tightly closed container. Definition: Niridazole contains not less than 97.0% and not more than 103.0% of C6H6N4O3S, calculated with reference to thedried substance.
DRUG BANK
DB13661
Created by admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
PRIMARY
FDA UNII
N116U8Y5QQ
Created by admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
PRIMARY
SMS_ID
100000083888
Created by admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
PRIMARY
EPA CompTox
DTXSID6045244
Created by admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
PRIMARY
WIKIPEDIA
Niridazole
Created by admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
PRIMARY
ChEMBL
CHEMBL152632
Created by admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
PRIMARY
MERCK INDEX
m7919
Created by admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
PRIMARY Merck Index
ECHA (EC/EINECS)
200-512-6
Created by admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
PRIMARY
CAS
61-57-4
Created by admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
PRIMARY
MESH
D009560
Created by admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
PRIMARY
HSDB
7480
Created by admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
PRIMARY
PUBCHEM
6093
Created by admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
PRIMARY
DRUG CENTRAL
1941
Created by admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
PRIMARY
EVMPD
SUB09304MIG
Created by admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
PRIMARY
NSC
136947
Created by admin on Fri Dec 15 15:03:42 GMT 2023 , Edited by admin on Fri Dec 15 15:03:42 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY